Gutiérrez R, Santander W, Mera G, Gutiérrez R, Calle C, Gutiérrez S

Language: Spanish
References: 10
Page: 236-241
PDF size: 301.25 Kb.

ABSTRACT

Alveolar hemorrhage is a medical emergency that compromises the patient’s life, which requires early and timely diagnosis and treatment. The clinical case of a patient who presented a hypertensive emergency associated with unknown renal disease with the need for chronic dialysis is presented. Subsequently, he developed a picture of diffuse alveolar hemorrhage, being a lung-kidney syndrome, for which reason immunological studies were requested, which revealed positivity for Anca P. Vasculitis associated with anticytoplasmic antibodies was suspected, for which treatment with corticosteroids and cyclophosphamide was started with Good respiratory clinical evolution, but not renal compromise, however, through complementary studies it was not possible to elucidate the definitive diagnosis

REFERENCES

1. Sethi, S., De Vriese, A. S., & Fervenza, F. C. (2022).Acute glomerulonephritis. Lancet (London, England),399(10335), 1646-1663. https://doi.org/10.1016/S0140-6736(22)00461-5

2. Geetha, D., & Jefferson, J. A. (2020). ANCA-AssociatedVasculitis: Core Curriculum 2020. American journal ofkidney diseases: the official journal of the National KidneyFoundation, 75(1),124–137. https://doi.org/10.1053/j.ajkd.2019.04.031

3. Jennette, J.C., y col. (2013). 2012 Revised InternationalChapel Hill Consensus Conference Nomenclature ofVasculitides. Arthritis & Rheumatism, 65:1-11.

4. Guchelaar, N. A. D., Waling, M. M., Adhin, A. A.,van Daele, P. L. A., Schreurs, M. W. J., & Rombach,S. M. (2021). The value of anti-neutrophil cytoplasmicantibodies (ANCA) testing for the diagnosis of ANCAassociated vasculitis, a systematic review and metaanalysis. Autoimmunity Reviews, 20(1),102716. https://doi.org/10.1016/j.autrev.2020.102716

5. Damoiseaux, J., y col. (2017). Detection ofantineutrophil cytoplasmic antibodies (ANCAs): Amulticentre European Vasculitis Study Group (EUVAS)evaluation of the value of indirect immunofluorescence(IIF) versus antigen-specific immunoassays. Annals ofthe Rheumatic Diseases, 76(4),647-653.

6. Ross, C., Makhzoum, J. P., & Pagnoux, C. (2022).Updates in ANCA-associated vasculitis. Europeanjournal of rheumatology, 9(3),153–166. https://doi.org/10.5152/eujrheum.2022.20248

7. Robson, J. C. y col. 2022 American College ofRheumatology/European Alliance of Associations forRheumatology classification criteria for granulomatosiswith polyangiitis. Annals of the rheumatic diseases,

8. 81(3),315–320. https://doi.org/10.1136/annrheumdis-2021-2217958) Sánchez de la Nieta García, M. D., y col.Glomerulonefritis con depósitos fibrilares simulandoenfermedad por anticuerpos antimembrana basalglomerular con microangiopatía trombótica asociaday ANCA P. Nefrología. https://doi.org/10.1016/j.nefro.2021.03.009

9. Mukhtyar C, Flossmann O, Hellmich B, et alOutcomes from studies of antineutrophil cytoplasmantibody associated vasculitis: a systematic review bythe European League Against Rheumatism systemicvasculitis task force. Annals of the Rheumatic Diseases2008;67:1004-1010.

10. Chung SA, Langford CA, Maz M, Abril A, Gorelik M,Guyatt G, Archer AM, Conn DL, Full KA, GraysonPC, Ibarra MF, Imundo LF, Kim S, Merkel PA, RheeRL, Seo P, Stone JH, Sule S, Sundel RP, VitobaldiOI, Warner A, Byram K, Dua AB, Husainat N, JamesKE, Kalot MA, Lin YC, Springer JM, Turgunbaev M,Villa-Forte A, Turner AS, Mustafa RA. 2021 AmericanCollege of Rheumatology/Vasculitis FoundationGuideline for the Management of AntineutrophilCytoplasmic Antibody-Associated Vasculitis. ArthritisRheumatol. 2021 Aug;73(8):1366-1383. doi: 10.1002/art.41773. Epub 2021 Jul 8. PMID: 34235894.